For example, high CXCL10 levels were associated with CD4+ and CD8+ T cell infiltration in the TME in breast cancer (48), but in CRC and NSCLC high CXCL10 levels were associated with shorter survival (15, 49). This evidence concerns the gene CXCL10 and breast carcinoma.